Is There a Vaccine for the CMV Virus?

CMV Virus Vaccine Clinical Study

CMV Virus Vaccine Clinical Study in Dallas

If you are a woman between the ages of 16 and 40 years of age, you are eligible to earn up to $2,000 as a participant in the CMV Virus Vaccine Clinical Study in Dallas. There is currently no vaccine available for CMV; however, with your participation in the clinical study, you can receive exclusive access to one that is currently seeking FDA approval. Keep reading to learn more about the CMV Virus Vaccine Clinical Study in Dallas and how to sign up as a participant today.

What Is The CMV Virus?

Cytomegalovirus (pronounced sy-toe-MEG-a-low-vy-rus), or CMV, is a common virus that infects people of all ages. Over half of adults have been infected with CMV by age 40. Most people infected with CMV show no signs or symptoms. When a baby is born with cytomegalovirus (CMV) infection, it is called congenital CMV. About one out of every 200 babies is born with congenital CMV infection. About one in five babies with congenital CMV infection will have long-term health problems.

CMV is spread from an infected person in the following ways:

  • From direct contact with saliva or urine, especially from babies and young children
  • Through sexual contact
  • From breast milk to nursing infants
  • Through transplanted organs and blood transfusions

Is There a Vaccine for the CMV Virus?

There is currently no vaccine available for the CMV virus, except for the one available to participants of the CMV Virus Vaccine Clinical Study in Dallas.

  • Healthy people who are infected with CMV usually do not require medical treatment.
  • Medications are available to treat CMV infection in people who have weakened immune systems and babies with signs of congenital CMV.
  • For babies with signs of congenital CMV infection at birth, antiviral medications, primarily valganciclovir, may improve hearing and developmental outcomes.
  • Valganciclovir can have serious side effects and has only been studied in babies with signs of congenital CMV infection.
  • There is limited information on the effectiveness of valganciclovir in treating infants with hearing loss alone.

Help the world avoid all of these issues and take part in our clinical study to advance the science and research surrounding the CMV Virus Vaccine.

What Is The CMV Virus Vaccine Clinical Study?

Dallas Clinical Research is currently conducting a Phase 3 clinical study for this vaccine. A Phase 3 clinical study compares the safety and effectiveness of the new treatment against the current standard treatment, has already been tested on groups of participants, and has been approved by the FDA to continue. As a participant, you can enjoy the following benefits:

  • Complimentary Consultation and Health Exam
  • Complimentary health exam and lab reports
  • Complimentary Study-Related Medicines
  • Guaranteed Compensation of up to $2,000

To sign up as a participant, all you need to do is click here to fill out a short form with your contact information. Once received, our team will reach out to you to determine eligibility (which may require a complimentary health exam at our clinic). If you meet the guidelines of the study, you will be asked to join as a paid participant.

For more information, visit us at!

Related Posts